Diagnosis, evaluation, and management of cognitive disorders in Parkinson's disease: Consensus recommendations from a modified Delphi process
- PMID: 40708679
- PMCID: PMC12287750
- DOI: 10.1002/dad2.70152
Diagnosis, evaluation, and management of cognitive disorders in Parkinson's disease: Consensus recommendations from a modified Delphi process
Abstract
Introduction: Variations in clinical management of cognitive disorders in Parkinson's disease (PD) can delay diagnosis, treatment, and care. To harmonize clinical practice, we aimed to gain consensus on best practice recommendations for the diagnosis, evaluation, and management of cognitive disorders in PD.
Method: Fifty-eight evidence-based recommendations were presented to an expert panel (N = 29) of Australian PD clinicians and researchers using a modified Delphi approach to gauge agreement. A 5-point Likert scale was used, with a median score > 4 and inter-quartile range < 1, indicating satisfactory agreement. Optional written feedback was also collected. A steering committee of clinicians, researchers, and lived experience experts (N = 13) revised recommendations based on panel feedback.
Results: Fifty-one evidence-based and expert-endorsed recommendations for the diagnosis, evaluation, and management of cognitive disorders in PD were produced.
Discussion: The recommendations serve as a foundational framework to guide clinical practice for cognitive disorders in PD and improve the provision of care.
Highlights: Recommendations for cognitive disorders in Parkinson's disease were developed.Diagnosis, evaluation, and management of cognitive disorders were explored.A modified Delphi approach was used.A panel of 29 Australian clinician and/or research experts provided input.Fifty-one evidence-based and expert-backed recommendations were developed.
Keywords: Parkinson's disease; cognitive impairment; dementia; guidelines.
© 2025 The Author(s). Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
The authors declare no conflicts of interest. All author disclosures are available in the supporting information.
Similar articles
-
Methodology for the systematic reviews on an evidence-based approach for the management of chronic low back pain.Spine (Phila Pa 1976). 2011 Oct 1;36(21 Suppl):S10-8. doi: 10.1097/BRS.0b013e31822ef8ee. Spine (Phila Pa 1976). 2011. PMID: 21952182
-
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Cochrane Database Syst Rev. 2012. PMID: 22419314 Free PMC article.
-
Expert perspectives on the use of safinamide for Parkinson's disease in Portugal: insights from a Portuguese Delphi Consensus.J Comp Eff Res. 2025 Jul;14(7):e240228. doi: 10.57264/cer-2024-0228. Epub 2025 Jun 6. J Comp Eff Res. 2025. PMID: 40474741 Free PMC article.
-
A minimally Invasive Biomarker for Sensitive and Accurate Diagnosis of Parkinson's Disease.medRxiv [Preprint]. 2024 Jun 30:2024.06.29.24309703. doi: 10.1101/2024.06.29.24309703. medRxiv. 2024. Update in: Acta Neuropathol Commun. 2024 Oct 22;12(1):167. doi: 10.1186/s40478-024-01873-1. PMID: 38978648 Free PMC article. Updated. Preprint.
-
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD012558. doi: 10.1002/14651858.CD012558.pub2. Cochrane Database Syst Rev. 2022. PMID: 35709018 Free PMC article.
References
LinkOut - more resources
Full Text Sources